CTLA4 and neoplasm: FoxP3 is a key regulatory gene for the development of Tregs that inhibits the antitumor immune response by producing immunosuppressive molecules, such as IL-10, CTLA-4 and PD-1, and releasing vascular endothelial growth factor (VEGF) to stimulate tumor angiogenesis (74, 75).